Initially, we utilized database available in GOBO site (Gene expression-based Outcome for Breast cancer Online; http://co.bmc.lu.se/gobo/gobo.pl) to compare the expression level of AGR2 and dystroglycan in more than 1,800 samples of breast tumors. This evidence concerns the gene AGR2 and breast carcinoma.